Marek Jan Orlowski

Marek Jan Orlowski is the founder of Nepentes SA (1991), Airway Medix SA (2013), and Adiuvo Investment SA (2013).
He is currently the Chairman-Management Board at Morluk Sp zoo, Nutra Sp zoo, Essenoids Sp zoo, and Director at Adiuhealth AG, Cambridge Chocolate Technologies Ltd., pHase2 microtechnologies, Inc., General Partner at Joint Polish Investment Fund Management BV (since 2015), and Member-Supervisory Board at Sound Object Technologies SA. He previously held positions such as Chief Executive Officer & Director at Airway Medix Sp ZOO, Chairman at Carocelle Sp zoo, Independent Director at Helix BioPharma Corp.
(2012-2019), Director at GreenLeaf Medical AB, Director at Helix Polska Sp zoo, Partner at Warsaw Sky-Warszawskie Niebo.
Sp zoo, Member-Supervisory Board at Humon Sp zoo, Glia Sp zoo, Imnta Sp zoo, Venture Advisor Sp zoo, Adiuvo Management Sp zoo, Member-Management Board at E-shopping Group SA, and Member-Supervisory Board at Helix Immuno-Oncology SA. He holds a doctorate degree from Warszawski Uniwersytet Medyczny.